Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (1205)	6/6/2000 10:33:00 AM
From: scott_jiminez	Read Replies (2) \| Respond to of 4474

I was told all the daytraders are broke.... ....selling pencils outside Horn & Hardart's. ARIA is now approaching a triple over the past 7 trading days. Could the sector be rumor-spiking vis-a-vis Ventner?? In any event, there's no doubt Ariad is leading the charge. Too bad so many on SI are blind to the idea of an incredibly versatile platform. Ariad would STILL be an excellent addition to the VD portfolio. Cytokine/Vector....? -------------- As of ~20 min ago (% chg, avg = +9.0%) - 1. aria 28.3 2. gene 15.0 3. absc 14.4 4. mygn 14.1 5. glgc 9.2 6. incy 9.1 7. affx 8.9 8. mlnm 8.6 9. hysq 6.2 10. vgin 4.9 11. hgsi 3.8 12. crgn 3.6 13. genxy 0.2 14. cra 0.0